Cargando…

Molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how?

Detalles Bibliográficos
Autor principal: Langabeer, Stephen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106119/
https://www.ncbi.nlm.nih.gov/pubmed/32269979
http://dx.doi.org/10.5045/br.2020.55.1.67
_version_ 1783512552488042496
author Langabeer, Stephen E.
author_facet Langabeer, Stephen E.
author_sort Langabeer, Stephen E.
collection PubMed
description
format Online
Article
Text
id pubmed-7106119
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-71061192020-04-08 Molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how? Langabeer, Stephen E. Blood Res Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2020-03 2020-03-30 /pmc/articles/PMC7106119/ /pubmed/32269979 http://dx.doi.org/10.5045/br.2020.55.1.67 Text en © 2020 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Langabeer, Stephen E.
Molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how?
title Molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how?
title_full Molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how?
title_fullStr Molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how?
title_full_unstemmed Molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how?
title_short Molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how?
title_sort molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106119/
https://www.ncbi.nlm.nih.gov/pubmed/32269979
http://dx.doi.org/10.5045/br.2020.55.1.67
work_keys_str_mv AT langabeerstephene molecularscreeningforanunderlyingmyeloproliferativeneoplasminpatientswithstrokewhoandhow